Sustainability reporting and governance
We are transparent about our impact on environment, people and society. For the benefit of all our stakeholders each year, we report on results and performance in the integrated Annual Report. Sustainability governance is an essential part of Mölnlycke corporate governance.
Mölnlycke’s non-financial reporting is based on the Global Reporting Initiative (GRI) principles and relevant standards, as well as the Greenhouse Gas (GHG) Protocol, supported by internally developed guidelines and third party audits of scope 1 and 2 emissions, and energy data. We listen attentively to internal and external stakeholders.
Mölnlycke´s integrated Annual Report 2023 covers the year ending on 31 December 2023. The report has been prepared in accordance with Global Reporting Initiative (GRI) standards, in addition to the Taskforce on Climate related Financial Disclosures (TCFD) framework.
Sustainability governance structure
Sustainability is integral to Mölnlycke’s business. The Executive Leadership Team (ELT) is responsible for integrating the sustainability roadmap into company strategy and monitoring the performance of each business and function. The Mölnlycke Board oversees the development of the sustainability roadmap, as well as approves the integrated Annual Report and the Sustainability Policy. The ELT formally reviews sustainability issues and associated impacts, risks and opportunities twice a year. In addition, critical concerns can be escalated to the team at any time.
Day-to-day responsibility for managing sustainability in Mölnlycke’s business and operational activities lies with the company’s Corporate Functions and Business Areas, supported by the COO and EVP Sustainability. The Sustainability function supports the Business Areas and Corporate Functions in defining and implementing their sustainability roadmaps. It also raises awareness of sustainability within the entire organisation, with the support of the Sustainability Committee. The governance of the ethical business aspects of our sustainability roadmap to 2030, WeCare, lies with the Business Ethics Compliance team, lead by the Chief Compliance Officer. To strengthen the internal focus and expertise on the topics of human and labour rights a dedicated Human Rights Committee has been formed. Finally, the Diversity, Equity & Inclusion (DEI) Council oversees and advances the development of Mölnlycke’s DEI vision.
Monitoring progress
Mölnlycke uses key performance indicators to track progress in delivering on the company’s sustainable business objectives and drive continual improvement processes in every function, supported by external benchmarks.
Latest news
-
Mölnlycke Health Care inaugurates new global headquarters at GoCo Health Innovation City
Gothenburg, Sweden. 21 May 2025 – Mölnlycke Health Care, a global leader in MedTech, has officially opened its new global headquarters at GoCo Health Innovation City in Gothenburg, Sweden—a major milestone in its journey to drive sustainable healthcare innovation.
-
Mölnlycke Health Care’s long-term target to reach net zero emissions validated by Science Based Targets initiative
Gothenburg, Sweden. 13 May, 2025. Mölnlycke’s long-term net zero greenhouse gas (GHG) emission reduction targets have been validated by the Science Based Targets initiative (SBTi), following prior validation of the company’s near-term GHG emission reduction targets.
-
Mölnlycke Health Care supports the Wound Care Collaborative Community initiative to improve wound dressing standards
Gothenburg, Sweden. May 02, 2025. The Wound Care Collaborative Community (WCCC) is leading a groundbreaking initiative looking to develop a standardised pre-clinical testing framework for wound dressings.
-
Mölnlycke Health Care publishes Annual report for 2024
Gothenburg, Sweden. 1 April 2025. Today Mölnlycke Health Care has published its Annual report for 2024, including the sustainability report.
-
New study demonstrates the potential benefits of dressing regime improvements in delivering value-based chronic wound care
-
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% to 60% to become majority shareholder in Tamer Mölnlycke Care - a joint venture with Tamer Group, the market leader in healthcare distribution in the Kingdom of Saudi Arabia.
-
Mölnlycke Health Care agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturizing.
-
Mölnlycke signs a EUR 350 million revolving credit facility
On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility. The facility has a tenor of five years with two one-year extension options and will be used as a backup for general corporate purposes. The facility is a refinancing of the existing and undrawn revolving credit facility signed in 2017.
-
Mölnlycke Health Care announces launch of the 2025 Future Summit
Mölnlycke Health Care’s Wound Care business area is delighted to announce the launch of its 2025 Future Summit, an educational event bringing together healthcare professionals (HCPs) from across Europe, the Middle East, and Africa (EMEA).